Newsroom

Vineti (formerly Vitruvian Networks)

June 21, 2017

News

FierceBiotech

Vineti scores $13M+, launches cloud-based platform for cell therapies

Vineti scores $13M+, launches cloud-based platform for cell therapies
June 20, 2017

News

GlobeNewswire

GE Ventures, Mayo Clinic Ventures and DFJ Invest $13.75M in First Software Platform to Accelerate Cancer Cure Process and Delivery

GE Ventures, Mayo Clinic Ventures and DFJ Invest $13.75M in First Software Platform to Accelerate Cancer Cure Process and Delivery
June 20, 2017

News

The Wall Street Journal

Vineti Takes Aim at Cancer Cell-Therapy Market With $13.8 Million Series A

Vineti Takes Aim at Cancer Cell-Therapy Market With $13.8 Million Series A
June 20, 2017

News

MedCity News

GE Ventures spin-out Vineti raises $13.75M for complex biomanufacturing

GE Ventures spin-out Vineti raises $13.75M for complex biomanufacturing
June 20, 2017

News

TechCrunch

GE and the Mayo Clinic back software to bring cancer-fighting gene therapies to market

GE and the Mayo Clinic back software to bring cancer-fighting gene therapies to market
January 12, 2017

News

Cell & Gene Therapy World

Vineti (formerly Vitruvian Networks) presents at Phacilitate Cell & Gene Therapy World 2017 Conference

Vineti (formerly Vitruvian Networks) presents at Phacilitate Cell & Gene Therapy World 2017 Conference
December 13, 2016

News

BusinessWire

Kite Pharma and Vineti (formerly Vitruvian Networks) Enter Strategic Partnership to Develop Best-In-Class Logistics and Data Analytics Software for Engineered T-cell Therapies at Commercial Scale

Kite Pharma and Vineti (formerly Vitruvian Networks) Enter Strategic Partnership to Develop Best-In-Class Logistics and Data Analytics Software for Engineered T-cell Therapies at Commercial Scale
October 4, 2016

News

Meeting on the Mesa

Vineti (formerly Vitruvian Networks) to present at Cell & Gene Meeting on the Mesa 2016

Vineti (formerly Vitruvian Networks) to present at Cell & Gene Meeting on the Mesa 2016
April 13, 2016

News

Vineti

Vineti (formerly Vitruvian Networks) proud to be an inaugural partner with Sean Parker’s $250M Institute for Cancer Immunotherapy

Vineti (formerly Vitruvian Networks) proud to be an inaugural partner with Sean Parker’s $250M Institute for Cancer Immunotherapy
April 11, 2016

News

GE Reports

New Digital Company Attacks Hard To Kill Cancer With Advanced Software And Manufacturing

New Digital Company Attacks Hard To Kill Cancer With Advanced Software And Manufacturing
April 11, 2016

News

GE

GE Ventures and Mayo Clinic Launch Company to Scale and Digitize Cell and Gene Therapies

GE Ventures and Mayo Clinic Launch Company to Scale and Digitize Cell and Gene Therapies